MARKET

CYPH

CYPH

Cypherpunk Technologies Inc
NASDAQ
0.6660
+0.0219
+3.40%
After Hours: 0.6890 +0.023 +3.45% 19:42 07/02 EDT
OPEN
0.7190
PREV CLOSE
0.6441
HIGH
0.7200
LOW
0.6500
VOLUME
2.14M
TURNOVER
--
52 WEEK HIGH
3.700
52 WEEK LOW
0.2323
MARKET CAP
70.91M
P/E (TTM)
-0.9699
1D
5D
1M
3M
1Y
5Y
1D
DLocal, Cypherpunk, BCE, LAC, Crinetics: Trending By Analysts
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
Cypherpunk Technologies Price Target Announced at $0.90/Share by Cantor Fitzgerald
Dow Jones · 3d ago
Cantor Fitzgerald Initiates Coverage On Cypherpunk Technologies with Overweight Rating, Announces Price Target of $0.9
Benzinga · 3d ago
Cypherpunk Technologies initiated with an Overweight at Cantor Fitzgerald
TipRanks · 4d ago
Weekly Report: what happened at CYPH last week (0622-0626)?
Weekly Report · 6d ago
Cypherpunk Shareholders Back Board, Pay and Auditor Choices
TipRanks · 06/22 20:57
Cypherpunk Technologies holds annual shareholder meeting
PUBT · 06/22 20:06
More
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.

Webull offers Cypherpunk Technologies Inc stock information, including NASDAQ: CYPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYPH stock methods without spending real money on the virtual paper trading platform.